Chembio Diagnostics, Inc. (CEMI): Price and Financial Metrics

CEMI POWR Grades

• CEMI scores best on the Value dimension, with a Value rank ahead of 67.65% of US stocks.
• CEMI's strongest trending metric is Quality; it's been moving up over the last 179 days.
• CEMI's current lowest rank is in the Sentiment metric (where it is better than 1.9% of US stocks).

CEMI Stock Summary

• CEMI has a higher market value than only 4.65% of US stocks; more precisely, its current market capitalization is $25,879,016.
• The volatility of Chembio Diagnostics Inc's share price is greater than that of 94.71% US stocks with at least 200 days of trading history.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CEMI comes in at -150.07% -- higher than that of only 2.17% of stocks in our set.
• Stocks that are quantitatively similar to CEMI, based on their financial statements, market capitalization, and price volatility, are ACIW, MKSI, MASS, CPSI, and LIVN.
• CEMI's SEC filings can be seen here. And to visit Chembio Diagnostics Inc's official web site, go to chembio.com.

CEMI Valuation Summary

• CEMI's price/earnings ratio is -3; this is 108.22% lower than that of the median Healthcare stock.
• Over the past 209 months, CEMI's price/sales ratio has gone down 1.3.
• Over the past 209 months, CEMI's price/earnings ratio has gone up 1.8.

Below are key valuation metrics over time for CEMI.

CEMI Growth Metrics

Its 4 year revenue growth rate is now at 34.1%.
• Its 4 year net income to common stockholders growth rate is now at -672.13%.
• The 5 year price growth rate now stands at 63.99%.

Over the past 34 months, CEMI's revenue has gone up $13,825,367.

The table below shows CEMI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	47.81845	-30.88572	-33.90353
2021-09-30	37.47188	-28.89083	-27.06958
2021-06-30	35.68591	-27.46491	-26.24253
2021-03-31	34.33497	-20.49654	-25.02194
2020-12-31	32.4702	-18.88724	-25.52133
2020-09-30	29.09398	-16.80419	-22.27106

CEMI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CEMI has a Quality Grade of F, ranking ahead of 4.04% of graded US stocks.
• CEMI's asset turnover comes in at 0.59 -- ranking 57th of 682 Pharmaceutical Products stocks.
• NEOG, CLVS, and ENDP are the stocks whose asset turnover ratios are most correlated with CEMI.

The table below shows CEMI's key quality metrics over time.